These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16211038)

  • 21. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
    J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsp90 as a therapeutic target in prostate cancer.
    Solit DB; Scher HI; Rosen N
    Semin Oncol; 2003 Oct; 30(5):709-16. PubMed ID: 14571418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
    Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K
    Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro combined modality treatment of prostate carcinoma cells with 17-(allylamino)-17-demethoxygeldanamycin and ionizing radiation.
    Ochel HJ; Gademann G
    Anticancer Res; 2006; 26(3A):2085-91. PubMed ID: 16827149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spinal and bulbar muscular atrophy (SBMA, Kennedy-Alter-Sung disease)].
    Tanaka F; Sobue G
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):375-8. PubMed ID: 10434677
    [No Abstract]   [Full Text] [Related]  

  • 27. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
    Moser C; Lang SA; Stoeltzing O
    Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.
    Maroney AC; Marugan JJ; Mezzasalma TM; Barnakov AN; Garrabrant TA; Weaner LE; Jones WJ; Barnakova LA; Koblish HK; Todd MJ; Masucci JA; Deckman IC; Galemmo RA; Johnson DL
    Biochemistry; 2006 May; 45(17):5678-85. PubMed ID: 16634649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
    Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma.
    Schmitt E; Maingret L; Puig PE; Rerole AL; Ghiringhelli F; Hammann A; Solary E; Kroemer G; Garrido C
    Cancer Res; 2006 Apr; 66(8):4191-7. PubMed ID: 16618741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Jin E and Santo M "Neurite outgrowth of NG08-15 cells induced by heat shock protein 90 inhibitors".
    Gold BG
    Cell Biochem Funct; 2008 Aug; 26(6):740. PubMed ID: 18720425
    [No Abstract]   [Full Text] [Related]  

  • 32. Androgen receptor mutation in Kennedy's disease.
    Fischbeck KH; Lieberman A; Bailey CK; Abel A; Merry DE
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1075-8. PubMed ID: 10434308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges of PK/PD measurements in modern drug development.
    Workman P
    Eur J Cancer; 2002 Nov; 38(16):2189-93. PubMed ID: 12387843
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction.
    Thomas M; Harrell JM; Morishima Y; Peng HM; Pratt WB; Lieberman AP
    Hum Mol Genet; 2006 Jun; 15(11):1876-83. PubMed ID: 16644868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
    Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional alterations in the androgen receptor in spinal bulbar muscular atrophy.
    McEwan IJ
    Biochem Soc Trans; 2001 May; 29(Pt 2):222-7. PubMed ID: 11356158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.
    Zhang MQ; Gaisser S; Nur-E-Alam M; Sheehan LS; Vousden WA; Gaitatzis N; Peck G; Coates NJ; Moss SJ; Radzom M; Foster TA; Sheridan RM; Gregory MA; Roe SM; Prodromou C; Pearl L; Boyd SM; Wilkinson B; Martin CJ
    J Med Chem; 2008 Sep; 51(18):5494-7. PubMed ID: 18800759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tanespimycin: the opportunities and challenges of targeting heat shock protein 90.
    Erlichman C
    Expert Opin Investig Drugs; 2009 Jun; 18(6):861-8. PubMed ID: 19466875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of a red-shifted fluorescence polarization probe for Hsp90.
    Moulick K; Clement CC; Aguirre J; Kim J; Kang Y; Felts S; Chiosis G
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4515-8. PubMed ID: 16797988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathogenesis of spinal and bulbar muscular atrophy.
    Merry DE
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):203-7. PubMed ID: 11719251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.